GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...
Time-of-day immunotherapy may represent a modifiable factor in cancer care, with earlier immune checkpoint inhibitor ...
Fecal microbiota transplantation is linked to improvements in both motor and non-motor outcomes in Parkinson’s disease, at least in the short term, a new meta-analysis shows.
GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose ...
High conversion rates to Parkinson's, dementia with Lewy bodies, or multiple system atroph ...
Coronary artery disease study shows similar mortality for CABG and PCI, but lower adverse events and revascularisation rates ...
Efficacy and safety analysis of adjuvant atezolizumab in non-small cell lung cancer patients in China: A single center retrospective analysis. This is an ASCO Meeting Abstract from the 2025 ASCO ...